GENUS INC
DEF 14A, 2000-04-20
SPECIAL INDUSTRY MACHINERY, NEC
Previous: PRICE T ROWE SMALL CAP VALUE FUND INC, 497K3B, 2000-04-20
Next: CTC COSMETICS HOLDINGS CO INC, DEF 14C, 2000-04-20





                            SCHEDULE 14A INFORMATION

                  Proxy Statement Pursuant to Section 14(a) of
                       the Securities Exchange Act of 1934

Filed  by  the  Registrant  [X]
Filed  by  a  Party  other  than  the  Registrant  [   ]

Check  the  appropriate  box:

[   ]     Preliminary  Proxy  Statement
[   ]     Confidential,  for  Use  of  the Commission Only (as permitted by Rule
          14a-6(e)(2)
[ X ]     Definitive  Proxy  Statement
[   ]     Definitive  Additional  Materials
[   ]     Soliciting  Material  Pursuant  to  Section  240.14a-11(c)  or Section
          240.14a-12

GENUS,  INC.
- ------------
(Name  of  Registrant  as  Specified  In  Its  Charter)


(Name  of  Person(s)  Filing  Proxy  Statement,  if  other  than the Registrant)

Payment  of  Filing  Fee  (Check  the  appropriate  box):

[ X ]     No  fee  required.
[   ]     Fee  computed  on  table  below per Exchange Act Rules 14a-6(i)(4) and
          0-11.

          (1)  Title  of  each class of securities to which transaction applies:

          (2)  Aggregate  number  of  securities  to  which transaction applies:

          (3)  Per  unit price or other underlying value of transaction computed
               pursuant to Exchange Act Rule 0-11 (set forth the amount on which
               the  filing  fee  is  calculated and state how it was determined:

          (4)  Proposed  maximum  aggregate  value  of  transaction:
          (5)  Total  fee  paid:

[   ]     Fee  paid  previously  with  preliminary  materials.
[   ]     Check box if any part of the fee is offset as provided by Exchange Act
          Rule  0-11(a)(2)  and identify the filing for which the offsetting fee
          was  paid  previously.  Identify  the  previous filing by registration
          statement  number, or the Form or Schedule and the date of its filing.

          (1)  Amount  Previously  Paid:
          (2)  Form,  Schedule  or  Registration  Statement  No.:
          (3)  Filing  Party:
          (4)  Date  Filed:

<PAGE>

                                   GENUS, INC.

                    NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
                           TO BE HELD ON MAY 31, 2000

TO  THE  SHAREHOLDERS:

     NOTICE  IS  HEREBY  GIVEN that the Annual Meeting of Shareholders of Genus,
Inc.  (the  "Company")  will  be  held on Wednesday, May 31, 2000 at 10:00 a.m.,
local time, at the Embassy Suites located at 2885 Lakeside Drive in Santa Clara,
California  95054,  for  the  following  purposes:

1.   To  elect  directors  to  serve  for  the  ensuing  year  and  until  their
     successors  are  elected.

2.   To  approve  the  adoption  of the Genus, Inc. 2000 Stock Option Plan which
     will  replace the 1991 Incentive Stock Option Plan and result in an overall
     increase  of  800,000  shares  available  for  issuance.

3.   To  approve  an  amendment  to  the  1989  Employee  Stock  Purchase  Plan
     increasing the number of shares reserved for issuance thereunder by 300,000
     additional  shares.

4.   To  ratify  the  appointment  of  PricewaterhouseCoopers LLP as independent
     accountants  of  the  Company's  financial  statements  for the fiscal year
     ending  December  31,  2000.

5.   To  transact such other business as may properly come before the meeting or
     any  adjournment  thereof.

     The  foregoing  items  of  business  are  more fully described in the Proxy
Statement  accompanying  this  Notice.

     Only  shareholders  of record at the close of business on April 3, 2000 are
entitled  to  vote  at  the  meeting.

     All  shareholders  are  cordially  invited to attend the meeting in person.
However,  to  ensure  your  representation at the meeting you are urged to mark,
sign,  date,  and  return the enclosed proxy card as promptly as possible in the
self-addressed  stamped  envelope  enclosed  for  that  purpose. Any shareholder
attending  the  meeting  may  vote in person even if he or she returned a proxy.

                                       THE  BOARD  OF  DIRECTORS



                                       WILLIAM  W.R.  ELDER
                                       Chairman  of  the  Board,  President  and
                                       Chief  Executive  Officer

Sunnyvale,  California
April  19,  2000

<PAGE>

                                   GENUS, INC.

             PROXY STATEMENT FOR 2000 ANNUAL MEETING OF SHAREHOLDERS

     The  enclosed  Proxy  is  solicited  on behalf of the Board of Directors of
Genus,  Inc.,  a  California  corporation (the "Company"), for use at the Annual
Meeting  of  Shareholders  (the  "Annual Meeting") to be held Wednesday, May 31,
2000  at 10:00 a.m., local time, or at any adjournment thereof, for the purposes
set  forth  herein  and  in  the  accompanying  Notice  of  Annual  Meeting  of
Shareholders.  The  Annual Meeting will be held at the Embassy Suites located at
2885  Lakeside  Drive  in Santa Clara, California 95054. The principal executive
offices of the Company are located at 1139 Karlstad Drive, Sunnyvale, California
94089.  The  Company's  telephone  number  at  that  location is (408) 747-7120.

     These  proxy  solicitation materials were mailed on or about April 28, 2000
to  all  shareholders  entitled  to  vote  at  the  meeting.

                 INFORMATION CONCERNING SOLICITATION AND VOTING

RECORD  DATE  AND  SHARE  OWNERSHIP

     Shareholders  of  record  at  the  close  of business on April 3, 2000 (the
"Record  Date")  are entitled to notice of and to vote at the Annual Meeting. At
the  Record Date, 18,770,364 shares of the Company's common stock, no par value,
were  issued  and  outstanding.

VOTING

     Each  share  of  common stock outstanding on the Record Date is entitled to
one vote. In addition, each shareholder on the Record Date, or his or her proxy,
may  cumulate  such shareholder's votes and give one candidate a number of votes
equal  to  the  number  of  directors  to be elected multiplied by the number of
shares  held  by  such shareholder, or distribute the shareholder's votes on the
same  principle among as many candidates as the shareholder may select, provided
that  votes  cannot  be  cast  for  more than four candidates. No shareholder or
proxy,  however, shall be entitled to cumulate votes for a candidate unless such
candidate's  name  has  been  placed  in  nomination prior to the voting and the
shareholder, or any other shareholder, has given notice at the meeting, prior to
the voting, of the shareholder's intention to cumulate votes. If any shareholder
gives  such  notice, all shareholders may cumulate their votes for candidates in
nomination.

QUORUM;  ABSTENTIONS;  BROKER  NON-VOTES

     The affirmative vote of a majority of the Votes Cast will be required under
California  law  to  approve  the  proposals  in  this Proxy Statement. For this
purpose,  the  "Votes Cast" are defined under California law to be the shares of
the  Company's  common  stock represented and "voting" at the Annual Meeting. In
addition,  the  affirmative  votes  must  constitute  at least a majority of the
required  quorum,  which  quorum  is a majority of the shares outstanding on the
Record  Date.  Votes  that  are  cast  against  the proposal will be counted for
purposes  of  determining  (i)  the presence or absence of a quorum and (ii) the
total  number  of  Votes  Cast  with  respect  to  the  proposal.

     While  there is no definitive statutory or case law authority in California
as  to the proper treatment of abstentions in the counting of votes with respect
to  a  proposal,  the  Company  believes  that abstentions should be counted for
purposes  of  determining  both (i) the presence or absence of a quorum and (ii)
the  total  number of Votes Cast with respect to the proposal. In the absence of
controlling  precedent to the contrary, the Company intends to treat abstentions
in  this  manner.  Accordingly,  abstentions will have the same effect as a vote
against  the  proposal.  Broker  non-votes  will  be  counted  for  purposes  of
determining  the  presence  or  absence of a quorum, but will not be counted for
purposes  of  determining the number of Votes Cast with respect to the proposal.

REVOCABILITY  OF  PROXIES

     Any  proxy given pursuant to this solicitation may be revoked by the person
giving  it  at  any time before its use by delivering to the Company (Attention:
Kenneth  Schwanda, Vice President of Finance, Chief Financial Officer) a written
notice  of  revocation  or  a  duly  executed  proxy  bearing a later date or by
attending  the  meeting  and  voting  in  person.

SOLICITATION

     The  cost  of soliciting proxies will be borne by the Company.  The Company
may  reimburse  brokerage firms and other persons representing beneficial owners
of  shares  for  their  expenses  in  forwarding  solicitation  material to such
beneficial  owners.  Proxies  may  be  solicited  by  certain  of  the Company's
directors,  officers  and  regular  employees,  without additional compensation,
personally  or  by  telephone,  telegram  or  facsimile.

DEADLINE  FOR  RECEIPT  OF  SHAREHOLDER  PROPOSALS

     Shareholders  who  intend  to  present  a  proposal  for  inclusion  in the
Company's  proxy  materials  for  the  2001  Annual Meeting of Shareholders must
submit  the  proposal  to  the  Company  no  later  than  December  25,  2000.
Additionally,  shareholders  who intend to present a proposal at the 2001 Annual
Meeting  of  Shareholders  without  inclusion  of such proposal in the Company's
proxy materials for the 2001 Annual Meeting must provide notice of such proposal
to  the  Company no later than December 29, 2000. The Company reserves the right
to  reject,  rule out of order, or take other appropriate action with respect to
any  proposal that does not comply with these and other applicable requirements.

SECURITY  OWNERSHIP  OF  CERTAIN  BENEFICIAL  OWNERS  AND  MANAGEMENT

     The  following  table  sets  forth certain information known to the Company
regarding beneficial ownership of the Company's common stock as of April 3, 2000
by (i) each of the Company's directors, (ii) each executive officer named in the
Summary  Compensation  Table appearing herein, (iii) all directors and executive
officers of the Company as a group, and (iv) each person known by the Company to
beneficially  own  more  than  5%  of  the  Company's  common  stock:

<TABLE>
<CAPTION>

NAME OF BENEFICIAL OWNER                                           NUMBER OF SHARES(1)  PERCENT OF CLASS(2)
- ----------------------------------------------------------------   -------------------  -------------------
<S>                                                                <C>                  <C>
Bachow Investment Partners III, L.P.                                           977,876                5.21%
 3 Bala Plaza East, Suite 502
 Bala Cynwyd, PA 19004
William W.R. Elder (3) . . . . . . . . . . . . . . . . . . . . .               555,599                2.96%
Kenneth Schwanda (4) . . . . . . . . . . . . . . . . . . . . . .                98,553                   *
Jeff Farrell (5) . . . . . . . . . . . . . . . . . . . . . . . .               120,894                   *
Mario M. Rosati (6). . . . . . . . . . . . . . . . . . . . . . .                32,750                   *
Thomas E. Seidel (7) . . . . . . . . . . . . . . . . . . . . . .               195,734                1.04%
Robert A. Wilson (8) . . . . . . . . . . . . . . . . . . . . . .                69,334                   *
G. Frederick Forsyth (9) . . . . . . . . . . . . . . . . . . . .                21,250                   *
Todd S. Myhre (10) . . . . . . . . . . . . . . . . . . . . . . .                88,785                   *
George D. Wells (11). . . . . . . . . . . . . . . . . . . . . .                 11,369                   *
Robert J. Richardson (12). . . . . . . . . . . . . . . . . . . .                 1,250                   *
All directors and executive officers as a group (10 persons) (13)            1,195,518                6.37%
<FN>

*  Less  than  1%.

</TABLE>

(1)   Except  as  otherwise  indicated  in  the  footnotes  to  this  table  and
      pursuant  to  applicable community property laws, the persons named in the
      table  have sole voting and investment power with respect to all shares of
      common  stock  shown  as  beneficially  owned  by  them.

(2)   Applicable  percentage  ownership  is based on 18,770,364 shares of common
      stock outstanding as of April 3, 2000 together with applicable options for
      such  shareholder.  Beneficial  ownership is determined in accordance with
      the  rules  of  the  Securities  and Exchange Commission, based on factors
      including  voting  and  investment power with respect to shares. Shares of
      common  stock subject to the options currently exercisable, or exercisable
      within  60 days of April 3, 2000, are deemed outstanding for computing the
      percentage  ownership  of  the  person  holding  such options, but are not
      deemed  outstanding  for  computing  the percentage ownership of any other
      person.

(3)   Consists  of 305,599 shares held by William W.R. Elder and Gloria S. Elder
      Family  Trust,  and  options  to  purchase  250,000 shares of common stock
      exercisable  within  60  days  of  April  3,  2000.

(4)   Consists  of  52,386 shares of common stock and options to purchase 46,167
      shares  of  common  stock  exercisable  within  60  days of April 3, 2000.

(5)   Consists  of  27,058 shares of common stock and options to purchase 93,836
      shares  of  common  stock  exercisable  within  60  days of April 3, 2000.

(6)   Consists  of  23,500  shares  held by Mr. Rosati, 11,500 shares held by WS
      Investment  Company  and  options to purchase 1,250 shares of common stock
      exercisable  within  60  days  of  April  3, 2000. Mr. Rosati is a general
      partner of WS Investment Company 92A and disclaims beneficial ownership of
      the  shares  held by such entity except to the extent of his proportionate
      partnership  interest  therein.

(7)   Consists  of 37,067 shares of common stock and options to purchase 158,667
      shares  of  common  stock  exercisable  within  60  days of April 3, 2000.

(8)   Consists  of  options  to  purchase  69,334  shares  of  common  stock
      exercisable  within  60  days  of  April  3,  2000.

(9)   Consists  of  options  to  purchase  21,250  shares  of  common  stock
      exercisable  within  60  days  of  April  3,  2000.

(10)  Consists  of  options  to  purchase  88,785  shares  of  common  stock
      exercisable  within  60  days  of  April  3,  2000.

(11)  Consists  of  options  to  purchase  1,250  shares  of  common  stock
      exercisable  within  60  days  of  April  3,  2000.

(12)  Consists  of  options  to  purchase  1,250  shares  of  common  stock
      exercisable  within  60  days  of  April  3,  2000.

(13)  Includes  options  to  purchase 731,789 shares of common stock exercisable
      within  60  days  of  April  3,  2000.

<PAGE>

                                  PROPOSAL ONE

                              ELECTION OF DIRECTORS

NOMINEES

     The  Company's  Bylaws  provide  for  a  variable  board  of  four to seven
directors,  with the number currently fixed at six. Unless otherwise instructed,
the  proxy  holders will vote the proxies received by them for the Company's six
nominees  named below, all of who are presently directors of the Company. In the
event  that  any  nominee  of  the  Company  is unable or declines to serve as a
director  at  the  time of the Annual Meeting, the proxies will be voted for any
nominee  who  shall  be designated by the present Board of Directors to fill the
vacancy. It is not expected that any nominee listed below will be unable or will
decline  to  serve  as  a  director.  In  the  event that additional persons are
nominated  for  election  as  directors,  the  proxy  holders intend to vote all
proxies  received  by them in such a manner in accordance with cumulative voting
as will assure the election of as many of the nominees listed below as possible,
and,  in such event, the specific nominees to be voted for will be determined by
the  proxy holders. The term of office of each person elected as a director will
continue  until  the  next Annual Meeting of Shareholders or until his successor
has  been  elected  and  qualified.

     The  names  of  the  nominees,  and certain information about them, are set
forth  below.

<TABLE>
<CAPTION>

NAME OF NOMINEE       AGE                             PRINCIPAL OCCUPATION                              DIRECTOR SINCE
- --------------------  ---  ---------------------------------------------------------------------------  --------------
<S>                   <C>  <C>                                                                          <C>
William W.R. Elder     61  Chairman of the Board, President and Chief Executive Officer of the Company            1981
Todd S. Myhre          54  International Business Consultant                                                      1994
G. Frederick Forsyth   56  President, Systems Engineering and Services of Solectron Corp.                         1996
Mario M. Rosati        53  Member of Wilson Sonsini Goodrich & Rosati, Professional Corporation                   1981
George D. Wells        64  Director                                                                               2000
Robert J. Richardson   54  Business Consultant                                                                    2000

</TABLE>

     Except  as  set  forth  below, each of the nominees has been engaged in his
principal  occupation  set  forth above during the past five years. There are no
family  relationships  among any directors or executive officers of the Company.

     William W.R. Elder was a founder of Genus and is our Chairman of the Board,
President  and our Chief Executive Officer. From October 1996 to April 1998, Dr.
Elder  served  only as Chairman of the Board. From April 1990 to September 1996,
Dr.  Elder  was  Chairman of the Board, President and Chief Executive Officer of
the  Company.  From  November  1981 to April 1990, Dr. Elder was President and a
director  of  the  Company.

     Todd  S. Myhre has served as a director since January 1994. Since September
1999,  he  served  as  Interim  Chief  Executive  Officer and a Board member for
Ybrain.com,  an  eCommerce  company  focused on the college student market. From
April  1998 to August 1999 and from September 1995 to January 1996, he served as
President,  Chief  Executive  Officer,  and  a  Board  member  of  GameTech
International, an electronic gaming manufacturer. From February 1996 to February
1998,  Mr.  Myhre was an international business consultant. From January 1993 to
August  1993,  from August 1993 to December 1993 and from January 1994 to August
1995,  Mr.  Myhre  served  as  Vice President and Chief Financial Officer of the
Company,  as  Executive  Vice  President  and  Chief  Operating  Officer  and as
President  and  a  Director  of  the  Company.

     G.  Frederick  Forsyth  has served as a director since February 1996. Since
March  1999,  Mr.  Forsyth  has  served  as  President,  Systems Engineering and
Services  of  Solectron Corp. From August 1997 to March 1999, Mr. Forsyth served
as  President,  Professional Products Division of Iomega, Inc. From June 1989 to
February  1997, Mr. Forsyth was associated with Apple Computer, Inc., a personal
computer  manufacturer, in various senior management positions, most recently as
Senior  Vice  President  and  General  Manager,  Macintosh  Product  Group.

     Mario  M.  Rosati  has  served  as  our  Secretary  since May 1996 and as a
director  since our inception in November 1981. Mr. Rosati is also a director of
Aehr Test Systems, a manufacturer of semiconductor test equipment; CATS Software
Inc.,  a  supplier  of  client/server  software  products  for  financial  risk
management;  Meridian  Data,  Inc., a developer of compact disc-read only memory
and  compact  disc-recordable systems and related software for both networks and
personal  computers;  Ross Systems, Inc., a supplier of enterprise-wide business
systems  and related services to companies installing open systems/client server
software  products;  and  Sanmina  Corporation,  an  electronics manufacturer of
multilayered  printed  circuit  boards, backplane assemblies, subassemblies, and
printed  circuit  board  assemblies.  Mr.  Rosati  is a member of Wilson Sonsini
Goodrich  &  Rosati,  P.C.,  general  counsel  to  the  Company.

     George  D.  Wells has served as a director since March 2000. From July 1992
to  October  1996,  Mr. Wells served as President and Chief Executive Officer of
Exar Corporation. From April 1985 to July 1992, he served as President and Chief
Operating  Officer of L.S.I. Logic Corporation and became Vice Chairman in March
1992.  From  May 1983 to April 1985, Mr. Wells was President and Chief Executive
Officer  of  Intersil,  Inc.,  a  subsidiary  of  General  Electric  Company.

     Robert  J.  Richardson  has  served  as  a director since March 2000. Since
January  2000, Mr. Richardson has been a semiconductor industry consultant. From
November  1997  to  January  2000,  Mr.  Richardson  served  as  Chairman, Chief
Executive  Officer  and  President  of  Unitrode  Corporation. From June 1992 to
November  1997,  he  served  in  various positions at Silicon Valley Group, Inc.
including  President  Lithography Systems, President Track Systems Division, and
Corporate  Vice-President  New  Business Development and Marketing. From October
1988  to June 1992, Mr. Richardson was President and General Manager, Santa Cruz
Division  at  Plantronics,  Inc.

VOTE  REQUIRED

     The  six  nominees receiving the highest number of affirmative votes of the
Votes  Cast  will  be  elected as directors of the Company for the ensuing year.

RECOMMENDATION

     THE  BOARD  OF  DIRECTORS  RECOMMENDS  THAT  THE  SHAREHOLDERS VOTE FOR THE
ELECTION  OF  THE  NOMINEES.

BOARD  MEETINGS  AND  COMMITTEES

     The  Board  of Directors of the Company held a total of six meetings during
the  year ended December 31, 1999. The Board of Directors has an Audit Committee
and  a  Compensation  Committee.  It  does  not have a nominating committee or a
committee  performing  the  functions  of  a  nominating  committee.

     During the year ended December 31, 1999, and as of April 3, 2000, the Audit
Committee of the Board of Directors, consisting of directors Forsyth, Myhre, and
Rosati,  held  one  meeting.  The  Audit  Committee recommends engagement of the
Company's independent accountants and is primarily responsible for approving the
services  performed  by  the Company's independent accountants and for reviewing
and  evaluating  the  Company's accounting principles and its system of internal
accounting  controls.

     During  the  year  ended  December  31,  1999, and as of April 3, 2000, the
Compensation  Committee  of  the  Board  of  Directors,  consisting of directors
Forsyth,  Myhre  and  Rosati, held one meeting. The Compensation Committee makes
recommendations  to  the  Board  of  Directors regarding the Company's executive
compensation  policy.  See  "Compensation  Committee  Report  on  Executive
Compensation."

     No  director  serving  in  the year ended December 31, 1999, attended fewer
than  75%  of  the  aggregate  number  of meetings of the Board of Directors and
meetings  of  the  committees  of  the  Board  on  which  he  or  she  serves.

DIRECTOR  COMPENSATION

     The  Company currently pays to its directors who are not employees a fee of
$1,000  per  meeting  and  $500 per telephonic meeting. In addition, the Company
pays  non-employee  members  of  the board an annual fee of $10,000. The Company
also  reimburses  directors  for  reasonable  expenses  incurred  in  attending
meetings.  Under  the  Company's  1991  Incentive Stock Option Plan, each of the
non-employee  directors  receives  an  automatic  grant of an option to purchase
5,000  shares  of common stock on the date of his or her appointment or election
to  the Board and, for so long as he or she continues to serve as a director, an
automatic  grant  of  an  option  to  purchase  5,000  shares of common stock on
February  7  of  each  year. There is no provision for an automatic grant to the
directors  in  the  2000  Stock Plan, presented to the shareholders for approval
hereto.  Therefore,  if the 2000 Stock Plan is approved, annual option grants to
the  directors  will  be  discretionary.

COMPENSATION  COMMITTEE  INTERLOCKS  AND  INSIDER  PARTICIPATION

     In 1999 the Company paid legal fees and expenses to Wilson Sonsini Goodrich
&  Rosati, Professional Corporation, general counsel to the Company. The amounts
paid by the Company to Wilson Sonsini Goodrich & Rosati were less than 5% of the
law  firm's  total  gross  revenues for its last completed fiscal year. Mario M.
Rosati,  a director and Secretary of the Company, is a member of the law firm of
Wilson  Sonsini  Goodrich  &  Rosati.

SECTION  16(A)  REPORTS

     Section 16(a) of the Securities Exchange Act of 1934 requires the Company's
officers  and directors, and persons who own more than 10% of a registered class
of  the Company's equity securities, to file certain reports regarding ownership
of,  and  transactions  in,  the  Company's  securities  with the Securities and
Exchange  Commission  (the "SEC"). Such officers, directors and 10% shareholders
are also required by SEC rules to furnish the Company with copies of all Section
16(a)  reports  that  they  file.

     Based  solely  on its review of the copies of such forms received by it, or
written  representations  from  certain  reporting persons, the Company believes
that  during  1999  its executive officers, directors and 10% shareholders filed
all required Section 16(a) reports on a timely basis, with the exception of Mike
Mitchell,  who  submitted  a  late  filing.

                         EXECUTIVE OFFICER COMPENSATION

SUMMARY  COMPENSATION  TABLE

     The  following table discloses compensation received by the Company's Chief
Executive  Officer and the four other most highly compensated executive officers
of the Company (the "Named Executive Officers") for the three fiscal years ended
December  31,  1999,  1998  and  1997:

<TABLE>
<CAPTION>

                                                                                           LONG TERM COMPENSATION
                                                                                                    AWARDS
                                                                                       ------------------------------
                                                                                       SECURITIES
                                                   ANNUAL COMPENSATION                 UNDERLYING
                                         -------------------------------------------
NAME AND PRINCIPAL POSITION      FISCAL                               OTHER ANNUAL       OPTIONS        ALL OTHER
                                  YEAR    SALARY ($)  BONUS ($)(1)  COMPENSATION ($)  (# OF SHARES)  COMPENSATION ($)
- -------------------------------  ------  -----------  ------------  ----------------  -------------  ----------------
<S>                              <C>     <C>          <C>           <C>               <C>            <C>
William W.R. Elder                 1999      300,000       95,000               --          50,000        12,296 (3)
Chairman of the Board,             1998      285,576           --               --         300,000         4,489 (4)
President and Chief Executive      1997      305,000           --               --              --         3,540 (5)
Officer (2)

Kenneth Schwanda. . . . . . . .    1999      133,343       32,400               --          80,000         1,695 (6)
 Vice President of Finance and.    1998      106,118           --               --          53,000         1,080 (7)
 Chief Financial Officer. . . .    1997       95,948           --               --          10,000           744 (8)

Thomas E. Seidel, Ph.D. . . . .    1999      210,000       58,800               --          30,000         4,829 (9)
 Executive Vice President and .    1998      210,000           --               --         200,000         5,895 (10)
 Chief Technical Officer. . . .    1997      209,200       21,000               --         125,000           948

Jeff Farrell. . . . . . . . . .    1999      152,630       37,200               --          30,000         2,011 (11)
Vice President of Engineering .    1998      144,922           --               --         107,000         2,272 (12)
                                   1997      141,284           --               --          10,000         1,612 (13)

Robert A. Wilson. . . . . . . .    1999      122,917           --      110,762 (14)         55,000         1,057 (17)
Vice President of Worldwide . .    1998       99,350           --       69,506 (15)         50,000           933 (18)
Sales . . . . . . . . . . . . .    1997       87,675           --       84,089 (16)             --           829 (19)

</TABLE>

(1)   Except as otherwise noted, all bonuses were earned by the named officer in
      fiscal  year  indicated  and  paid  to  the  named  officer  early  in the
      subsequent  year  pursuant  to  the  Company's  Management Incentive Plan.

(2)   Dr.  Elder  was  re-appointed  President  and  Chief  Executive Officer in
      April  1998.

(3)   Consists  of  insurance  premiums  of  $11,496  for  a  group  term  life
      insurance  policy,  the  proceeds  of  which  were  payable to Dr. Elder's
      named  beneficiaries,  and  matched  401(k)  contribution  of  $800.

(4)   Consists  of  insurance  premiums  of  $4,489  for  a  term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Dr.  Elder's  named
      beneficiaries.

(5)   Consists  of  insurance  premiums  of  $3,540  for  a  term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Dr.  Elder's  named
      beneficiaries.

(6)   Consists  of  insurance  premiums  of $628 for a group term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Mr. Schwanda's named
      beneficiaries,  and  matched  401(k)  contribution  of  $1,067.

(7)   Consists  of  insurance  premiums  of $231 for a group term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Mr. Schwanda's named
      beneficiaries,  and  matched  401(k)  contribution  of  $849.

(8)   Consists  of  insurance  premiums  of $149 for a group term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Mr. Schwanda's named
      beneficiaries,  and  matched  401(k)  contribution  of  $595.

(9)   Consists  of  insurance premiums of $4,269 for a group term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Dr.  Seidel's  named
      beneficiaries,  and  matched  401(k)  contribution  of  $560.

(10)  Consists  of  insurance  premiums  of  $5,335  for  a  group  term  life
      insurance policy, the proceeds of which were payable to Dr. Seidel's named
      beneficiaries,  and  matched  401(k)  contribution  of  $560.

(11)  Consists  of  insurance  premiums  of  $1,184  for  a  group  term  life
      insurance  policy,  the  proceeds  of  which were payable to Mr. Farrell's
      named  beneficiaries,  and  matched  401(k)  contribution  of  $827.

(12)  Consists  of  insurance  premiums  of  $1,452  group  term  life insurance
      policy,  the  proceeds  of  which  were  payable  to  Mr.  Farrell's named
      beneficiaries,  and  matched  401(k)  contribution  of  $820.

(13)  Consists  of  insurance  premiums  of $848 for a group term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Mr.  Farrell's named
      beneficiaries,  and  matched  401(k)  contribution  of  $764.

(14)  Consists  of  sales  commissions  of  $110,762.

(15)  Consists  of  sales  commissions  of  $69,506.

(16)  Consists  of  sales  commissions  of  $84,089.

(17)  Consists  of  insurance  premiums  of $240 for a group term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Mr.  Wilson's  named
      beneficiaries,  and  matched  401(k)  contribution  of  $817.

(18)  Consists  of  insurance  premiums  of $191 for a group term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Mr.  Wilson 's named
      beneficiaries,  and  matched  401(k)  contribution  of  $742.

(19)  Consists  of  insurance  premiums  of $166 for a group term life insurance
      policy,  the  proceeds  of  which  were  payable  to  Mr.  Wilson 's named
      beneficiaries,  and  matched  401(k)  contribution  of  $663.

<PAGE>

OPTION/SAR  GRANTS  IN  LAST  FISCAL  YEAR

     The  following  table  provides information on option grants made in fiscal
1999  to  the  Named  Executive  Officers.  No  SARs  were  granted.

<TABLE>
<CAPTION>

                      INDIVIDUAL GRANTS
                    ----------------------
                                % OF TOTAL                            POTENTIAL REALIZABLE VALUE
                     NUMBER OF    OPTIONS                              AT ASSUMED ANNUAL RATES
                    SECURITIES  GRANTED TO                                  OF STOCK PRICE
                    UNDERLYING   EMPLOYEES   EXERCISE                   APPRECIATION FOR OPTION
                      OPTIONS    IN FISCAL   PRICE PER    EXPIRATION          TERM (3)
NAME                  GRANTED     YEAR (1)  SHARE ($)(2)     DATE         5% ($)       10% ($)
- ------------------  ----------  ----------  ------------  ----------  ------------  ------------
<S>                 <C>         <C>         <C>           <C>         <C>           <C>
William W.R. Elder      50,000       10.4%         3.094    07/23/04    $   42,750    $   94,450
Kenneth Schwanda .      30,000        6.3%         2.375    02/08/04        19,680        43,500
                        50,000       10.4%         3.094    07/23/04        42,750        94,450
Thomas E. Seidel .      30,000        6.3%         3.094    07/23/04        25,650        56,670
Jeff Farrell . . .      30,000        6.3%         3.094    07/23/04        25,650        56,670
Robert A. Wilson .      30,000        6.3%         2.375    02/08/04        19,680        43,500
                        25,000        5.2%         3.094    07/23/04        21,375        47,225

</TABLE>

(1)   Based  on  an aggregate of 478,624 options granted to all employees during
      fiscal  year  1999. Options granted in fiscal year 1999 expire in 2004 and
      typically  vest in three equal annual installments commencing on the first
      anniversary  of  the  date  of  grant.

(2)   All  options  were  granted  at an exercise price equal to the fair market
      value  based  on  the  closing  market value of common stock on the Nasdaq
      National Market  on  the date of grant with the exception of those options
      that  were  repriced  as  disclosed.

(3)   Potential realizable value assumes that the stock price increases from the
      date  of grant until the end of the option term (five years) at the annual
      rate  specified  (5%  and  10%). This assumption is based on SEC rules and
      does  not  necessarily  represent  the  expected  rate  of  appreciation.

AGGREGATED  OPTION/SAR  EXERCISES  IN  LAST  FISCAL  YEAR  AND  FISCAL  YEAR-END
OPTION/SAR  VALUES

      The following table provides information on option exercises in fiscal
1999  by the Named Executive Officers and the number and value of such officers'
unexercised  options  at  December  31,  1999.  No  SARs  have  been  granted.

<TABLE>
<CAPTION>

                       SHARES       VALUE    NUMBER OF UNEXERCISED OPTIONS     VALUE OF UNEXERCISED
                    ACQUIRED ON   REALIZED         DECEMBER 31, 1999          IN-THE-MONEY OPTIONS AT
                                             -----------------------------   DECEMBER 31, 1999 ($)(2)
      NAME          EXERCISE (#)   ($) (1)   EXERCISABLE     UNEXERCISABLE  EXERCISABLE  UNEXERCISABLE
- ------------------  ------------  ---------  -----------     -------------  -----------  -------------
<S>                 <C>           <C>        <C>             <C>            <C>          <C>
William W.R. Elder           -0-        --       250,000           250,000      582,850        795,300
Kenneth Schwanda .           -0-        --        35,834           118,666       71,447        236,904
Thomas E. Seidel .           -0-        --       198,335           171,665      437,065        541,705
Jeff Farrell . . .           -0-        --        54,835           104,665      128,804        248,362
Robert A. Wilson .           -0-        --        35,001            95,999       74,850        205,994

</TABLE>

(1)   Market  value  of underlying securities (based on the fair market value of
      the  Company's  common stock on the Nasdaq National Market) at the time of
      exercise,  minus  the  exercise  price.

(2)   Market  value  of securities underlying in-the-money options at the end of
      fiscal year 1999 (based on $4.50 per share, the closing price of Company's
      common stock on the Nasdaq National Market on December 31, 1999), less the
      exercise  price.

     The  Company  has  not established any long-term incentive plans or defined
benefit  or  actuarial  plans  covering  any  of  the  Named Executive Officers.

                          COMPENSATION COMMITTEE REPORT

EXECUTIVE  COMPENSATION

     The  objectives  of  the  overall  executive  compensation  program  are to
attract,  retain,  motivate  and  reward Company executives while aligning their
compensation  with  the achievements of key business objectives, maximization of
shareholder  value  and  optimal  satisfaction  of  customers.

     The  Compensation  Committee  is  responsible  for:

1.   Determining  the  specific executive compensation methods to be used by the
     Company  and  the  participants  in  each  of  those  specific  programs;

2.   Determining  the  evaluation  criteria  and  timelines  to be used in those
     programs;

3.   Determining  the  processes  that  will  be  followed  in  the  ongoing
     administration  of  the  programs;  and

4.   Determining  their  role  in  the  administration  of  the  programs.

     All  of  the  actions take the form of recommendations to the full Board of
Directors  where  final  approval,  rejection  or  redirection  will  occur. The
Compensation  Committee  is  responsible  for  administering  the  compensation
programs  for all Company officers. The Compensation Committee has delegated the
responsibility  of administering the compensation programs for all other Company
employees  to  the  Company's  officers.

     Currently,  the Company uses the following executive compensation vehicles:

     -  Cash-based  programs:  Base  salary, Annual Incentive Bonus Plan, Annual
        Profit  Sharing  Plan,  and  a  Sales  Incentive  Commission  Plan;  and

     -  Equity-based  programs: 1991 Incentive Stock Option Plan (to be replaced
        by  the  2000  Stock Plan pending shareholder approval of the 2000 Stock
        Plan)  and  the  1989  Employee  Stock  Purchase  Plan.

     These programs apply to the Chief Executive Officer and all executive level
positions,  except  for the Sales Incentive Commission Plan, which only includes
executives directly responsible for sales activities. Periodically, but at least
once  near the close of each fiscal year, the Compensation Committee reviews the
existing plans and recommends those that should be used for the subsequent year.

     The  criteria for determining the appropriate salary level, bonus and stock
option grants for the Chief Executive Officer and each of the executive officers
include (a) Company performance as a whole, (b) business unit performance (where
appropriate)  and (c) individual performance objectives. Company performance and
business  unit  performance  are  measured  against both strategic and financial
goals.  Examples of these goals are to obtain: operating profit, revenue growth,
timely  new product introduction, and shareholder value (usually measured by the
Company  stock price). Individual performance is measured to specific objectives
relevant  to  the  individual's  position  and  a  specific  time  frame.

     These  criteria  are usually related to a fiscal year time period, but may,
in  some  cases,  be  measured  over  a  shorter  or  longer  time  frame.

     The  processes  used  by  the  Compensation Committee include the following
steps:

1.   The  Compensation Committee periodically receives information comparing the
     Company's  pay  levels  to  other  companies  in  similar industries, other
     Leading  companies  (regardless  of  industry)  and  competitors. Primarily
     national  and  regional  compensation  surveys  are  used.

2.   At  or  near the start of each evaluation cycle, the Compensation Committee
     meets  with  the  Chief  Executive Officer to review, revise as needed, and
     agree  on the performance objectives set for the other executives reporting
     to  the  Chief  Executive  Officer.  The  Chief  Executive  Officer  and
     Compensation  Committee  jointly set the Company objectives to be used. The
     business unit and individual objectives are formulated jointly by the Chief
     Executive Officer and the specific  individual.  The Compensation Committee
     also,  with  the Chief Executive Officer, jointly establishes and agrees on
     their  respective  performance  objectives.

3.   Throughout  the performance cycle review, feedback is provided by the Chief
     Executive  Officer,  the  Compensation  Committee  and  full  Board,  as
     appropriate.

4.   At  the  end  of  the  performance  cycle,  the  Chief  Executive Officer
     evaluates  each  executive's  relative  success  in meeting the performance
     goals.  The  Chief Executive Officer makes recommendations on salary, bonus
     and  stock  options,  utilizing  the  comparative results as a factor. Also
     included  in the decision criteria are subjective factors such as teamwork,
     leadership contributions  and  ongoing changes in the business climate. The
     Chief  Executive  Officer  reviews  the  recommendations  and  obtains
     Compensation Committee approval. The Compensation Committee also determines
     the  level of salary and bonus and the terms of stock option grants for the
     Chief  Executive  Officer.

5.   The  final  evaluations  and compensation decisions are discussed with each
     executive  by  the  Chief  Executive  Officer or Compensation Committee, as
     appropriate.

     The Compensation Committee feels that the compensation vehicles used by the
Company, generally administered through the process as outlined above, provide a
fair  and balanced executive compensation program related to the proper business
issues.  In  addition,  it  should  be  noted that compensation vehicles will be
reviewed  and,  as  appropriate,  revised  in  order  to  attract and retain new
executives  in  addition  to  rewarding  performance  on  the  job.

                                      Respectfully  submitted  by:

                                      Frederick  Forsyth
                                      Todd  S.  Myhre
                                      Mario  M.  Rosati

<PAGE>

                                PERFORMANCE GRAPH

     The  following  graph  shows  a  comparison of cumulative total shareholder
return  among  the  Company,  the  NASDAQ  Stock  Market-US  Index and the H & Q
Technology  Index  for  the  period from December 31, 1994 (the last trading day
before the beginning of the Company's 1995 Fiscal Year) through 1999 Fiscal Year
End  for  the Company. The graph assumes that $100 was invested in the Company's
common  stock,  in the NASDAQ Stock Market-US Index and the H&Q Technology Index
on  December  31,  1994  and all dividends were reinvested. Historic stock price
performance  is  not  necessarily  indicative of future stock price performance.

     EDGAR  REPRESENTATION  OF  DATA  POINTS  USED  IN  PRINTED  GRAPHIC

<TABLE>
<CAPTION>

       GENUS, INC.  NASDAQ STOCK MARKET (U.S.)  H&Q TECHNOLOGY
       -----------  --------------------------  ---------------
<S>    <C>          <C>                         <C>
12/94  $       100      $        100                $       100
12/95           94               141                        150
12/96           69               174                        186
12/97           42               213                        218
12/98           13               300                        339
12/99           56               542                        757

</TABLE>

                                 PROPOSAL  TWO

                     APROVAL OF ADOPTION OF 2000 STOCK PLAN

TERMINATION  OF  GENUS,  INC.  1991  INCENTIVE  STOCK  OPTION  PLAN

     The  Company has terminated its 1991 Incentive Stock Option Plan (the "1991
Plan")  which was due to expire in February 2001. The Company has authorized the
adoption  of  a  2000  Stock  Plan  (the  "Plan"),  outlined below, and solicits
shareholder  approval  of  the  Plan.  The Company reserves a total of 4,803,006
shares  for  issuance under the Plan, which increases the total number of shares
available  for  issuance  by 800,000. Any stock reserved but remaining ungranted
under  the  1991  Plan  shall remain with the Company as authorized but unissued
common  stock.

DESCRIPTION  OF  THE  GENUS,  INC.  2000  STOCK  PLAN

     General.  The  purpose  of  the  Plan  is  to  attract  and retain the best
available  personnel  for  positions  of  substantial  responsibility  with  the
Company,  to  provide  additional  incentive to the employees and consultants of
the  Company  and  its  subsidiaries and to promote the success of the Company's
business. Options granted under the Plan may be either "incentive stock options"
or  nonstatutory  stock options. Stock purchase rights may also be granted under
the  Plan.

     Administration.  The  Plan  may generally be administered by the Board or a
Committee  appointed  by  the  Board  (as  applicable, the "Administrator"). The
Administrator  may make any determinations deemed necessary or advisable for the
Plan.

     Eligibility.  Nonstatutory  stock  options and stock purchase rights may be
granted  under  the  Plan to employees, directors and consultants of the Company
and  any  parent  or  subsidiary  of the Company. Incentive stock options may be
granted  only  to  employees.  The Administrator, in its discretion, selects the
employees,  directors  and consultants to whom options and stock purchase rights
may  be  granted,  the  time  or  times at which such options and stock purchase
rights  shall be granted, and the exercise price and number of shares subject to
each  such  grant.

     Limitations.  Section 162(m) of the Code places limits on the deductibility
for  federal  income  tax  purposes  of  compensation  paid to certain executive
officers  of  the  Company. In order to preserve the Company's ability to deduct
the  compensation  income  associated  with options granted to such persons, the
Plan  provides  that  no  employee  may  be  granted,  in any fiscal year of the
Company,  options  or stock purchase rights to purchase more than 750,000 shares
of  common  stock.  Notwithstanding this limit, however, in connection with such
individual's  initial  employment  with  the  Company,  he or she may be granted
options  or stock purchase rights to purchase up to an additional 750,000 shares
of  common  stock.

     Terms and Conditions of Options. Each option is evidenced by a stock option
agreement  between the Company and the optionee, and is subject to the following
terms  and  conditions:

     (a)  Exercise  Price.  The  Administrator  determines the exercise price of
options  at the time the options are granted. The exercise price of an incentive
stock  option  may  not be less than 100% of the fair market value of the common
stock  on  the date such option is granted; provided, however, that the exercise
price  of an incentive stock option granted to a 10% shareholder may not be less
than  110% of the fair market value on the date such option is granted. The fair
market  value  of the common stock is generally determined with reference to the
closing  sale  price  for  the common stock (or the closing bid if no sales were
reported)  on  the  last  market  trading  day  prior  to the date the option is
granted.

     (b) Exercise of Option; Form of Consideration. The Administrator determines
when  options  become  exercisable  and  may,  in its discretion, accelerate the
vesting  of  any outstanding option. The means of payment for shares issued upon
exercise  of  an  option is specified in each option agreement. The Plan permits
payment to be made by cash, check, promissory note, other shares of common stock
of  the  Company (with some restrictions), cashless exercises, any other form of
consideration  permitted  by  applicable  law,  or  any  combination  thereof.

     (c)  Term  of  Option. The term of an incentive stock option may be no more
than  ten (10) years from the date of grant; provided, however, that in the case
of  an  incentive  stock  option  granted  to a 10% shareholder, the term of the
option  may be no more than five (5) years from the date of grant. No option may
be  exercised  after  the  expiration  of  its  term.

     (d)  Termination  of  Service.  If  an  optionee's  service  relationship
terminates  for  any  reason  (excluding death or disability), then the optionee
generally  may  exercise  the  option  within 30 days of such termination to the
extent  that  the  option is vested on the date of termination, (but in no event
later  than the expiration of the term of such option as set forth in the option
agreement).  If  an  optionee's  service  relationship  terminates  due  to  the
optionee's  disability,  the  optionee generally may exercise the option, to the
extent  the option was vested on the date of termination, within six months from
the  date  of such termination. If an optionee's service relationship terminates
due  to  the  optionee's death, the optionee's estate or the person who acquires
the  right  to  exercise  the  option  by  bequest  or inheritance generally may
exercise  the  option,  as to all of the shares subject to the option (including
unvested  shares),  within  six  months  from  the  date  of  such  termination.

     (e)  Nontransferability  of  Options.  Unless  otherwise  determined by the
Administrator, options granted under the Plan are not transferable other than by
will  or  the  laws of descent and distribution, and may be exercised during the
optionee's  lifetime  only  by  the  optionee.

     (f)  Other  Provisions. The stock option agreement may contain other terms,
provisions and conditions not inconsistent with the Plan as may be determined by
the  Administrator.

     Stock  Purchase  Rights.  In  the case of stock purchase rights, unless the
Administrator  determines  otherwise,  the  restricted  stock purchase agreement
shall  grant  the  Company a repurchase option exercisable upon the voluntary or
involuntary  termination  of the purchaser's employment with the Company for any
reason  (including  death  or  disability).  The  purchase  price  for  shares
repurchased  pursuant  to  the  restricted stock purchase agreement shall be the
original  price  paid  by  the  purchaser and may be paid by cancellation of any
indebtedness  of the purchaser to the Company. The repurchase option shall lapse
at  a  rate  determined  by  the  Administrator.

     Adjustments  Upon Changes in Capitalization. In the event that the stock of
the  Company  changes  by  reason of any stock split, reverse stock split, stock
dividend,  combination, reclassifi-cation or other similar change in the capital
structure  of  the  Company  effected  without  the  receipt  of  consideration,
appropriate adjustments shall be made in the number and class of shares of stock
subject  to  the  Plan,  the  number and class of shares of stock subject to any
option  or  stock  purchase  right  outstanding under the Plan, and the exercise
price  of  any  such  outstanding  option  or  stock  purchase  right.

     In  the  event  of a liquidation or dissolution, any unexercised options or
stock  purchase  rights  will  terminate.  The  Administrator  may,  in its sole
discretion,  provide  that each optionee shall have the right to exercise all or
any part of the option or stock purchase right, including shares as to which the
option  or  stock  purchase  right  would  not  otherwise  be  exercisable.

     In  connection  with  any  merger  of  the  Company  with  or  into another
corporation  or  the  sale  of  all  or  substantially  all of the assets of the
Company, each outstanding option and stock purchase right shall be assumed or an
equivalent  option  or  right  substituted  by the successor corporation. If the
successor  corporation  refuses to assume the options or rights or to substitute
substantially equivalent options or rights, the optionee shall have the right to
exercise  the  option  or  stock  purchase  right  as to all the optioned stock,
including  shares  not  otherwise  vested  or  exercisable.  In  such event, the
Administrator  shall notify the optionee that the option or stock purchase right
is fully exercisable for fifteen (15) days from the date of such notice and that
the  option  terminates  upon  expiration  of  such  period.

     Amendment  and Termination of the Plan. The Board may amend, alter, suspend
or  terminate  the  Plan,  or  any part thereof, at any time and for any reason.
However,  the Company shall obtain stockholder approval for any amendment to the
Plan  to  the  extent  necessary and desirable to comply with applicable law. No
such  action  by  the  Board  or  stockholders  may  alter  or impair any option
previously  granted  under the Plan without the written consent of the optionee.
Unless  terminated earlier, the Plan shall terminate ten years from the date the
Plan  or  any amendment to add shares to the Plan was last adopted by the Board.

FEDERAL  INCOME  TAX  CONSEQUENCES

     Incentive  Stock  Options.  An  optionee  who is granted an incentive stock
option  does  not  recognize taxable income at the time the option is granted or
upon  its  exercise, although the exercise is an adjustment item for alternative
minimum  tax  purposes  and  may subject the optionee to the alternative minimum
tax.  Upon  a  disposition  of the shares more than two years after grant of the
option and one year after exercise of the option, any gain or loss is treated as
long-term  capital  gain  or loss. Net capital gains on shares held more than 12
months may be taxed at a maximum federal rate of 20%. Capital losses are allowed
in  full  against  capital gains and up to $3,000 against other income. If these
holding  periods  are  not satisfied, the optionee recognizes ordinary income at
the  time  of disposition equal to the difference between the exercise price and
the  lower  of (i) the fair market value of the shares at the date of the option
exercise  or  (ii)  the sale price of the shares. Any gain or loss recognized on
such  a  premature  disposition of the shares in excess of the amount treated as
ordinary  income  is  treated  as  long-term or short-term capital gain or loss,
depending  on the holding period. A different rule for measuring ordinary income
upon  such a premature disposition may apply if the optionee is also an officer,
director, or 10% shareholder of the Company. Unless limited by Section 162(m) of
the  Code,  the  Company  is  entitled  to a deduction in the same amount as the
ordinary  income  recognized  by  the  optionee.

     Nonstatutory  Stock  Options.  An  optionee  does not recognize any taxable
income  at  the  time  he  or  she  is granted a nonstatutory stock option. Upon
exercise,  the  optionee  recognizes  taxable  income  generally measured by the
excess  of the then fair market value of the shares over the exercise price. Any
taxable  income  recognized in connection with an option exercise by an employee
of  the  Company is subject to tax withholding by the Company. Unless limited by
Section  162(m)  of the Code, the Company is entitled to a deduction in the same
amount  as the ordinary income recognized by the optionee. Upon a disposition of
such  shares  by  the  optionee,  any  difference between the sale price and the
optionee's  exercise  price,  to  the extent not recognized as taxable income as
provided  above,  is  treated  as  long-term or short-term capital gain or loss,
depending  on  the holding period. Net capital gains on shares held more than 12
months may be taxed at a maximum federal rate of 20%. Capital losses are allowed
in  full  against  capital  gains  and  up  to  $3,000  against  other  income.

     Stock Purchase Rights. Stock purchase rights will generally be taxed in the
same  manner as nonstatutory stock options. However, restricted stock is subject
to  a  "substantial  risk of forfeiture" within the meaning of Section 83 of the
Code,  because the Company may repurchase the stock when the purchaser ceases to
provide  services  to  the  Company.  As  a  result  of this substantial risk of
forfeiture,  the  purchaser  will  not  recognize ordinary income at the time of
purchase.  Instead,  the  purchaser  will recognize ordinary income on the dates
when  the  stock is no longer subject to a substantial risk of forfeiture (i.e.,
when  the Company's right of repurchase lapses). The purchaser's ordinary income
is  measured  as  the  difference between the purchase price and the fair market
value  of  the  stock  on  the  date  the stock is no longer subject to right of
repurchase.

     The purchaser may accelerate to the date of purchase his or her recognition
of ordinary income, if any, and begin his or her capital gains holding period by
timely  filing  (i.e.,  within  30  days  of  purchase), an election pursuant to
Section  83(b)  of  the  Code. In such event, the ordinary income recognized, if
any,  is  measured  as  the  difference  between the purchase price and the fair
market  value of the stock on the date of purchase, and the capital gain holding
period commences on such date. The ordinary income recognized by a purchaser who
is  an  employee  will  be  subject to tax withholding by the Company. Different
rules  may  apply  if  the  purchaser  is  also  an  officer,  director,  or 10%
shareholder  of  the  Company.

     THE  FOREGOING  IS  ONLY A SUMMARY OF THE EFFECT OF FEDERAL INCOME TAXATION
UPON OPTIONEES AND THE COMPANY WITH RESPECT TO THE GRANT AND EXERCISE OF OPTIONS
UNDER THE PLAN. IT DOES NOT PURPORT TO BE COMPLETE, AND DOES NOT DISCUSS THE TAX
CONSEQUENCES  OF  THE  EMPLOYEE'S OR CONSULTANT'S DEATH OR THE PROVISIONS OF THE
INCOME  TAX  LAWS  OF  ANY  MUNICIPALITY,  STATE OR FOREIGN COUNTRY IN WHICH THE
EMPLOYEE  OR  CONSULTANT  MAY  RESIDE.

VOTE  REQUIRED

     Affirmative  votes  constituting  a  majority  of  the  Votes  Cast will be
required  to adopt the 2000 Stock Plan and reserve 4,803,006 shares for issuance
thereunder.

RECOMMENDATION

     THE  BOARD  OF  DIRECTORS  RECOMMENDS  THAT  THE  SHAREHOLDERS VOTE FOR THE
ADOPTION  OF  THE  2000  STOCK  PLAN.

<PAGE>

                                 PROPOSAL THREE

                 AMENDMENT OF 1989 EMPLOYEE STOCK PURCHASE PLAN

GENERAL

     The  1989 Employee Stock Purchase Plan ("Purchase Plan") was adopted by the
board  of  Directors in March 1989 and approved by the shareholders in May 1990.
In  March  2000,  the  Board  of Directors amended the Purchase Plan, subject to
shareholder  approval, to increase the number of shares of common stock reserved
for  issuance  thereunder by 300,000 shares, from 2,350,000 to 2,650,000 shares.
As  of  April 3, 2000, 2,168,794 shares had been issued under the Purchase Plan,
and  181,206  shares  remained available for future issuances under the Purchase
Plan.

PURPOSE

     The  purpose  of  the  Purchase Plan is to provide employees of the Company
(and any of its subsidiaries which are designated by the Board of Directors) who
participate  in  the  plan  with  an opportunity to purchase common stock of the
Company  through  payroll  deductions.

ADMINISTRATION

     The  Purchase  Plan  may  be  administered  by  the Board of Directors or a
committee appointed by the Board. All questions of interpretation or application
of  the  plan are determined at the sole discretion of the Board of Directors or
its committee. The Purchase Plan is currently being administered by the Board of
Directors.  Members  of  the  Board  of Directors who are eligible employees are
permitted  to  participate  in  the Purchase Plan but may not vote on any matter
affecting  the administration of the plan or the grant of any option pursuant to
the  plan,  or be a member of any committee appointed to administer the plan. No
charges  for  administrative  or  other  costs  may  be made against the payroll
deductions  of  a  participant  in  the  plan. Members of the Board of Directors
receive  no  additional  compensation  for their services in connection with the
administration  of  the  Purchase  Plan.

ELIGIBILITY

     Any  person  who  is employed by the Company (or by any of its subsidiaries
which  are  designated from time-to-time by the Board) for at least 20 hours per
week  and  more  than  five  months  in  a  calendar year on the date his or her
participation  in  the  plan  is  effective  is  eligible  to participate in the
Purchase  Plan.  As of April 3, 2000 approximately 72 employees were eligible to
participate  in  the  Purchase  Plan.

OFFERING  DATE

     The  Purchase  Plan is implemented by overlapping 24-month offering periods
containing  four six-month purchase periods. New offering periods commence every
six  months.  The purchase periods generally commence on July 1 and January 1 of
each  year.  The  Board  of  Directors  may  change the duration of the offering
periods  without  shareholder  approval.

PURCHASE  PRICE

     The  purchase  price  per share at which shares are sold under the Purchase
Plan is the lower of 85% of fair market value of the common stock on the date of
commencement  of the 24-month offering period or 85% of the fair market value of
the  common  stock  on  the  last day of the six-month purchase period. Eligible
employees are automatically re-enrolled in the offering period with the lower of
85% of fair market value of the common stock on the date of commencement of such
24-month  offering  period. The fair market value of the common stock on a given
date  shall  be  determined  by  the  Board of Directors based upon the reported
closing  price  in  the  Nasdaq  National  Market  System  on  such  date.

PAYMENT  OF  PURCHASE  PRICE;  PAYROLL  DEDUCTIONS

     The  purchase  price  of  the  shares  is accumulated by payroll deductions
during the offering period. The deductions may not exceed 10% of a participant's
eligible compensation. A participant may discontinue his or her participation in
the  plan  or  may decrease, but not increase, the rate of payroll deductions at
any  time  during  the  offering  period.

     All  payroll deductions are credited to the participant's account under the
plan  and  are  deposited  with  the  general  funds of the Company. All payroll
deductions  received  or  held by the Company may be used by the Company for any
corporate  purpose.

PURCHASE  OF  STOCK;  EXERCISE  OF  OPTION

     At  the  beginning  of  each  offering  period, by executing a subscription
agreement  to  participate  in  the  Purchase  Plan,  each employee is in effect
granted  an  option  to  purchase  shares of common stock. The maximum number of
shares  placed  under  option  to  a participant in an offering is determined by
dividing  the  compensation  which such participant has elected to have withheld
during  the  offering period by 85% of the fair market value of the common stock
at  the  beginning  of  the  offering  period  or  ending  of a purchase period,
whichever  is  lower.

WITHDRAWAL

     While  each  participant  in  the  Purchase  Plan  is  required  to  sign a
subscription  agreement  authorizing  payroll  deductions,  the  participant's
interest  in  a  given  offering may be terminated in whole, but not in part, by
signing and delivering to the Company a notice of withdrawal from the plan. Such
withdrawal  may  be  elected  at  any  time  prior  to the end of the applicable
24-month  offering  period. A participant's withdrawal from an offering does not
have any effect upon such participant's eligibility to participate in subsequent
offerings  under  the  Purchase  Plan.

TERMINATION  OF  EMPLOYMENT

     Termination  of  a  participant's  employment  for  any  reason,  including
retirement  or  death,  cancels  his  or  her participation in the Purchase Plan
immediately. In such event, the payroll deductions credited to the participant's
account  will  be  returned to such participant or, in the case of death, to the
person  or  persons  entitled  thereto  as  specified  by  the  employee  in the
subscription  agreement.

CHANGES

     In  the  event of any change, such as stock splits or stock dividends, made
in  the capitalization of the Company that results in an increase or decrease in
the  number  of  shares  of  common  stock  outstanding  without  receipt  of
consideration  by  the  Company,  appropriate  adjustments  will  be made by the
Company  in  the  number of shares subject to purchase and in the purchase price
per  share,  subject  to any required action by the shareholders of the Company.

AMENDMENT  AND  TERMINATION  OF  THE  PLAN

     The  Board  of  Directors  may  at any time amend or terminate the Purchase
Plan,  except  that such termination shall not affect options previously granted
nor  may  any amendment make any change in an option granted prior thereto which
adversely affects the rights of any participant. No amendment may be made to the
Purchase  Plan  without  approval  of  the  shareholders  of the Company if such
amendment  would  increase  the  number  of  shares reserved under the plan. The
Purchase  Plan  will  by  its  terms  terminate  in  2009.

TAX  INFORMATION

     The  Purchase  Plan,  and  the  right  of  participants  to  make purchases
thereunder,  is intended to qualify under the provisions of Sections 421 and 423
of  the Code. Under these provisions, no income will be taxable to a participant
until  the  shares  purchased  under the Plan are sold or otherwise disposed of.
Upon  sale or other disposition of the shares, the participant will generally be
subject to tax and the amount of the tax will depend upon the holding period. If
the  shares are sold or otherwise disposed of more than two years from the first
day  of the offering period and one year from the date the shares are purchased,
the participant will recognize ordinary income measured as the lesser of (a) the
excess  of  the  fair  market  value  of  the shares at the time of such sale or
disposition  over  the purchase price, or (b) an amount equal to 15% of the fair
market  value  of  the  shares  as  of the first day of the offering period. Any
additional  gain  will  be  treated as long-term capital gain. If the shares are
sold  or  otherwise  disposed of before the expiration of these holding periods,
the  participant will recognize ordinary income generally measured as the excess
of the fair market value of the shares on the date the shares are purchased over
the purchase price. Any additional gain or loss on such sale or disposition will
be  long-term  or  short-term  capital  gain  or  loss, depending on the holding
period. The Company is not entitled to a deduction for amounts taxed as ordinary
income  or capital gain to a participant except to the extent of ordinary income
recognized  by  participants  upon  a sale or disposition of shares prior to the
expiration  of  the  holding  period(s)  described  above.

     The  foregoing  is  only a summary of the effect of federal income taxation
upon  the participant and the Company with respect to the shares purchased under
the  Purchase Plan. Reference should be made to the applicable provisions of the
Code.  In  addition,  the  summary  does  not  discuss the tax consequences of a
participant's  death  or  the income tax laws of any state or foreign country in
which  the  participant  may  reside.

VOTE  REQUIRED

     The approval of the amendment to the Purchase Plan requires the affirmative
vote  of  a  majority  of  the  Votes  Cast.

RECOMMENDATION

     THE  BOARD  OF  DIRECTORS  RECOMMENDS  THAT  THE  SHAREHOLDERS VOTE FOR THE
APPROVAL  OF  THE  AMENDMENT  TO  THE  1989  EMPLOYEE  STOCK  PURCHASE  PLAN.

<PAGE>

                                  PROPOSAL FOUR

             RATIFICATION OF APPOINTMENT OF INDEPENDENT ACCOUNTANTS

     The Board of Directors has selected PricewaterhouseCoopers LLP, independent
accountants,  to  audit  the  financial  statements  of the Company for the year
ending  December  31,  2000,  and  recommends  that  the  shareholders  vote for
ratification  of  such  appointment.  In  the  event  of a negative vote on such
ratification,  the  Board  of  Directors  will  reconsider  its  selection.
PricewaterhouseCoopers  LLP has audited the Company's financial statements since
the  year ended December 31, 1982. Representatives of PricewaterhouseCoopers LLP
are  expected  to  be  present  at  the  meeting  with the opportunity to make a
statement  if  they desire to do so, and are expected to be available to respond
to  appropriate  questions.

                                  OTHER MATTERS

     The  Company  knows  of no other matters to be submitted to the meeting. If
any  other  matters properly come before the meeting, it is the intention of the
persons named in the enclosed form of Proxy to vote the shares they represent as
the  Board  of  Directors  may  recommend.

                                              THE  BOARD  OF  DIRECTORS


Dated:  April  19,  2000

<PAGE>

           THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

                                   GENUS, INC.

                       2000 ANNUAL MEETING OF SHAREHOLDERS

     The  undersigned  shareholder of GENUS, INC., a California corporation (the
"Company"),  hereby  acknowledges  receipt  of  the  Notice of Annual Meeting of
Shareholders and Proxy Statement, each dated April 19, 2000, and hereby appoints
William W.R. Elder and Kenneth Schwanda proxies and attorneys-in-fact, with full
power  of  substitution,  on  behalf  and  in  the  name  of the undersigned, to
represent  the  undersigned at the 2000 Annual Meeting of Shareholders of Genus,
Inc.  to  be  held  on Wednesday, May 31, 2000 at 10:00 a.m., local time, at the
Embassy  Suites located at 2885 Lakeside Drive in Santa Clara, California 95054,
and  any  continuation(s)  or  adjournment(s) thereof, and to vote all shares of
common  stock  which the undersigned would be entitled to vote if then and there
personally  present,  on  the  matters  set  forth  below.

                           -  FOLD AND DETACH HERE  -

                                                                Please mark your
                                                           choice like this  [X]

                                                                   -------------
                                                                          COMMON

                      FOR all nominees listed     WITHHOLD authority to vote
                      below (except as indicate   for all nominees listed below.

1.   Election  of  directors:   [   ]                        [   ]

     IF  YOU  WISH  TO  WITHHOLD  AUTHORITY  TO VOTE FOR ANY INDIVIDUAL NOMINEE,
     STRIKE  A  LINE  THROUGH  THAT  NOMINEE'S  NAME  IN  THE  LIST  BELOW:

     William  W.R.  Elder, Todd S. Myhre, G. Frederick Forsyth, Mario M. Rosati,
     George  D.  Wells,  and  Robert  J.  Richardson

2.   Proposal  to  approve  the  adoption  of  the Company's 2000 Stock Plan and
     reserve  4,803,006  shares for issuance thereunder, which replaces the 1991
     Incentive  Stock  Option  Plan and increases the number of shares available
     for  issuance  by  800,000.

              FOR               AGAINST               ABSTAIN
             [   ]               [   ]                 [   ]

3.   Proposal  to  approve  the  amendment  of the Company's 1989 Employee Stock
     Purchase Plan to increase the number of shares of common stock reserved for
     issuance  thereunder  by  300,000  shares.

              FOR               AGAINST               ABSTAIN
             [   ]               [   ]                 [   ]

4.   Proposal  to  ratify  the  appointment of PricewaterhouseCoopers LLP as the
     independent  public  accountants  of the Company's financial statements for
     the  fiscal  year  ending  December  31,  2000.

              FOR               AGAINST               ABSTAIN
             [   ]               [   ]                 [   ]

5.   In  the  discretion of the proxy holders, upon such other matter or matters
     which  may  properly  come  before  the  meeting and any continuation(s) or
     adjournment(s)  thereof.

              FOR               AGAINST               ABSTAIN
             [   ]               [   ]                 [   ]

THIS  PROXY WILL BE VOTED AS DIRECTED OR, IF NO CONTRARY DIRECTION IS INDICATED,
WILL  BE VOTED FOR THE ELECTION OF DIRECTORS, FOR THE ADOPTION OF THE 2000 STOCK
PLAN,  FOR  THE  AMENDMENT  OF  THE  1989  EMPLOYEE STOCK PURCHASE PLAN, FOR THE
RATIFICATION  OF  THE  APPOINTMENT  OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT
PUBLIC  ACCOUNTANTS, AND IN THE DISCRETION OF THE PROXY HOLDERS, UPON SUCH OTHER
MATTER  OR  MATTERS  WHICH  MAY  PROPERLY  COME  BEFORE  THE  MEETING  AND  ANY
CONTINUATION(S)  OR  ADJOURNMENT(S)  THEREOF.

Signature(s)                                             Date  __________,  2000

(This  Proxy should be dated, signed by the shareholder(s) exactly as his or her
name  appears  hereon,  and  returned promptly in the enclosed envelope. Persons
signing  in a fiduciary capacity should so indicate. If shares are held by joint
tenants  or  as  community  property,  both  should  sign.)

                           -  FOLD AND DETACH HERE  -



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission